#ACC2024 was action packed and full of insightful conversations. 🫀 Cardiology thought leaders, Milind Desai MD MBA Dr. Payal Kohli, MD Matthew W Martinez Omar M. Abdelfattah, MD, FESC Joshua Lampert, MD shared the latest real-world data for Viz HCM and the potential of AI in the cardiovascular space.

Experts share how they are harnessing point-of-care AI to set new benchmarks for commercial success. Join the live discussion with AstraZeneca @Genentech IPG Health and Viz.ai on Thurs April 25: bit.ly/3VG1WRP
#pharmaAI #commercialstrategy

Incredible work by the NICONeuroCorp team 👏 on ENRICH, the first positive trial to improve functional and economic outcomes for intracerebral hemorrhage (ICH). Read the full release 👉 niconeuro.com/the-new-englan…

In partnership with Becker's Hospital Review, read this article to learn from two healthcare AI experts who shared how to successfully select and deploy AI solutions in their hospital. 👉 beckershospitalreview.com/responsible-ai…

How can we unite behind the value of AI and pull colleagues and partners with us in pharma's journey? Read our blog reflecting on the recent Reuters Events Pharma USA Conference where we discussed how pharma can effectively unite around AI and adopt it into their organization's clinical,…

Our very own Chief Medical Officer Sommer will join Reuters Events Pharma alongside AstraZeneca, Genentech and Viz.ai to discuss how point-of-care AI is being used to improve patient outcomes. Be sure to tune in!

Don't miss Regulating Medical AI — Staying Safe in the Fast Lane taking place tomorrow 4/10 @ 12 pm ET hosted by NEJM AI. Our VP of Quality & Regulatory Affairs, Jeff Naveda will join #ClinicalAI experts for a lively discussion on the regulation of AI in medicine. Register to…

Join our upcoming webinar with @ReutersEvents: 'Point-of-care AI: The new imperative for pharma commercial strategy'
📅 Date: April 25
🕐 Time: 1 pm ET

Don't miss this opportunity to learn from industry experts about the crucial role of AI in shaping pharma commercial…

Congratulations to Dr. Payal Kohli and Dr. Joshua Lampert on receiving these distinguished awards at #ACC24 this weekend. Thank you both for your significant contributions in transforming #CardiovascularCare and improving heart health around the world.

Join Dr. Omar Abdelfattah, Dr. Matthew W Martinez, & Viraj Bhatt on the last day of #ACC24 , sharing their research on 'Racial & Phenotypic Variations in Detecting Hypertrophic Cardiomyopathy Using AI-Enabled ECG' Explore AI in cardiology at Hall B4-5, 10:45 am. #patientsfirst

Join our upcoming webinar in partnership with Becker's Hospital Review, 'Responsible AI: Streamlining Care Enterprise Wide', On April 23 at 12 pm CT. Save your seat today: go.beckershospitalreview.com/hit/responsibl… #VizaiOne #HealthcareAI

📑 3 studies that will be presented at #ACC2024 this weekend have shown positive outcomes with real-world impact of Viz.ai in clinical practice for patients with hypertrophic cardiomyopathy (HCM)🫀 viz.ai/news/viz-ai-an…

How many more cryptogenic stroke patients could benefit from cardiology follow-up to reduce the risk of secondary stroke? Chat with Dr. Hsu at #ACC2024 in the Viz.ai booth #3921 this Sunday between 2-4 pm. Save to your calendar 👉 viz.ai/events/acc-202…

Accuracy Matters. Viz.ai reliably detects chronic subdural hematoma (cSDH), enabling physicians to activate care, quickly. Recent studies at #ISC24 (EMBOLISE, STEM, MAGIC-MT) show positive outcomes with MMA embolization. Learn more about Viz Subdural: viz.ai/subdural?utm_s…

San Francisco-based Viz.ai uses algorithms to examine medical imagery and patient tests to detect critical conditions such as stroke or pulmonary embolism. #FCMostInnovative bit.ly/3vdRyWN

We're looking forward to the next webinar from
NEJM AI on April 10! Our VP of Quality + Regulatory Affairs, Jeff Naveda will join leading experts in #ClinicalAI on the regulation of #AIinMedicine . Tune in @ 12 pm ET for Regulating #MedicalAI - Staying Safe in the Fast Lane…

We're delighted to announce that we're collaborating with Medtronic to improve post-acute stroke care in the U.S.! 🤝 Our collaboration aims to enhance coordination between neurology 🧠 and cardiology 🫀 teams using our Viz CONNECT® solution. viz.ai/news/viz-ai-an… #StrokeCare

💡Read McKinsey & Company's insights on the challenges and opportunities in modernizing biopharma commercial models to boost patient value. From improving access to therapy to embracing AI. mckinsey.com/industries/lif… #PharmaAI #AIinHealthCare #AIinPharma

Dr. Isaac Kohane joined NEJM as a member of the editorial board in 2019 where he focused on the evaluation of investigations that used AI methodologies. Dr. Kohane serves as the Editor-in-Chief of NEJM AI.

View full speaker lineup: nejm.ai/3In5two

🏅We have been recognized as a Comparably Best Place to Work for our company outlook—that's three years in a row! Looking to join our amazing team? Check out our careers page for current openings! viz.ai/careers #BestPlacetoWork2024 #ComparablyAwards